The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States
NCT06309914, Not applicable, Completed, Applied Science & Performance Institute
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States | ClinicalTrials.gov |
| NCT number | NCT06309914 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 76 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Applied Science & Performance Institute | ClinicalTrials.gov |
| Conditions | Mental Processes, Cognitive Change, Mood Change | ClinicalTrials.gov |
| Interventions | Placebo, Enovita Grape Seed Extract, Mirtoselect Bilberry Extract, Virtiva Plus Ginko Biloba Extract | ClinicalTrials.gov |
| First posted | 2024-03-13 | ClinicalTrials.gov |
| Last updated | 2024-07-30 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Visual Memory | Baseline, Day 28 | The visual memory test measures how well a subject can recognize, remember, and retrieve geometric figures or spatial representations. | ClinicalTrials.gov |
| Primary | Change in Verbal Memory | Baseline, Day 28 | The verbal memory test measures how well a subject can recognize, remember, and retrieve words. | ClinicalTrials.gov |
| Primary | Change in Finger Tapping Test (FTT) Results | Baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on Day 0, and Day 28. | The FTT measures the speed and number of finger-taps on each hand. This tests the motor speed and fine motor capability of subjects. | ClinicalTrials.gov |
| Primary | Change in Symbol Digit Coding (SDC) Test Results | Baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on Day 0, and Day 28. | Measures the speed of processing while drawing upon several cognitive processes simultaneously (i.e., visual scanning, visual perception, visual memory, and motor functions). | ClinicalTrials.gov |
| Primary | Change in Stroop Test Results | Baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on Day 0, and Day 28. | Assesses the ability to inhibit cognitive interference that occurs when the processing of a stimulus impedes the simultaneous processing of a second stimulus. | ClinicalTrials.gov |
| Primary | Change in Shifting Attention Test Results | Baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on Day 0, and Day 28. | Measures a subject's executive function (i.e., rules, categories, decision making) or their ability to shift from one instruction set to another quickly and accurately. | ClinicalTrials.gov |
| Primary | Change in Continuous Performance Test Results | Baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on Day 0, and Day 28. | Measures vigilance or sustained attention over time. | ClinicalTrials.gov |
| Secondary | Change in Abbreviated Profile of Mood States (POMS) Score | Baseline, 60 mins post-supplementation on day 0, 180 mins post-supplementation on day 0, and Day 28. | Changes assessed in the abbreviated profile of mood states for subjective assessment of the subject's mood and overall well-being. It is a 40 point scale, divided into 7 different subscales, with a 5 point Likert scale, ranging from 0 (not at all) to 4 (Extremely) of how a subject feels in response to that particular feeling. The following equation is used to determine the overall score: Total Mood Disturbance = \[Tension+Depression+Anger+Fatigue+Confusion\] - \[Vigor+Esteem Related Affect\]. A lower score indicates overall better mood, while a lower score indicates worse overall mood | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Continuous Performance Test | Primary outcome | ConductCognition |
| Finger Tapping Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)